Auna (NYSE:AUNA – Get Free Report) and biote (NASDAQ:BTMD – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, risk, institutional ownership and valuation.
Profitability
This table compares Auna and biote’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Auna | 0.44% | 12.88% | 3.24% |
| biote | -1.08% | -8.61% | 4.61% |
Earnings & Valuation
This table compares Auna and biote”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Auna | $4.67 billion | 0.07 | $27.39 million | $0.07 | 66.09 |
| biote | $178.91 million | 0.20 | $27.05 million | ($0.10) | -9.73 |
Auna has higher revenue and earnings than biote. biote is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
21.7% of biote shares are held by institutional investors. 32.4% of biote shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current recommendations and price targets for Auna and biote, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Auna | 1 | 2 | 1 | 1 | 2.40 |
| biote | 1 | 1 | 1 | 1 | 2.50 |
Auna currently has a consensus price target of $6.97, suggesting a potential upside of 50.60%. biote has a consensus price target of $2.50, suggesting a potential upside of 156.94%. Given biote’s stronger consensus rating and higher probable upside, analysts clearly believe biote is more favorable than Auna.
Volatility & Risk
Auna has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, biote has a beta of 1.73, indicating that its stock price is 73% more volatile than the S&P 500.
Summary
biote beats Auna on 7 of the 13 factors compared between the two stocks.
About Auna
Auna S.A. is a Latin American healthcare company that provides medical care through a network of hospitals, clinics and specialized treatment centers. Its services include general and specialty care, diagnostic services and cancer treatment. The company also offers health plans and other healthcare financing services, integrating coverage with care delivery. Auna serves patients in Peru, Colombia and Mexico.
About biote
Biote is a medical technology and services company focused on hormone optimization. It supports healthcare providers who offer bioidentical hormone replacement therapy (BHRT), including pellet-based treatment programs for eligible patients. The company’s services include provider training and education, patient and practice support, and hormone testing and treatment protocols. Biote also offers nutritional supplements and related wellness products through participating providers. Biote was founded in 2012 and serves a network of healthcare providers in the United States.
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
